Kras Pharmaceuticals Private Limited

Manufactures and trades pharmaceutical products since 1985 in Bihar.

1985 | Patna, Bihar (India) | Active
Last Updated: December 24, 2024

Kras Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 1.50 Cr
  • Company Age 39 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.22 Cr
  • Revenue Growth 51.47%
  • Profit Growth 34.41%
  • Ebitda 685.75%
  • Net Worth 2.15%
  • Total Assets 34.82%

About Kras Pharmaceuticals

Kras Pharmaceuticals Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 September 1985 and has a history of 39 years and four months. Its registered office is in Patna, Bihar, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.

The company currently has active open charges totaling ₹3.22 Cr.

The Key Managerial Personnel (KMP) at Kras Pharmaceuticals Private Limited India is Rupesh Kumar as CEO. Rupesh Kumar, Ravi Shankar, and Vinita Bhushan serve as directors at the Company.

Company Details

  • Location

    Patna, Bihar, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U00304BR1985PTC002219

  • Company No.

    002219

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    27 Sep 1985

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Patna

Industry

Pharma

Who are the key members and board of directors at Kras Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Rupesh Kumar CEO21-Feb-2020Current

Board Members (3)

NameDesignationAppointment DateStatus
Rupesh Kumar Country flag representing In Director 01-Sep-2020Current
Ravi Shankar Country flag representing In Director 02-Jan-2019Current
Vinita Bhushan Country flag representing In Director 01-Sep-2020Current

Financial Performance of Kras Pharmaceuticals.

Kras Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 51.47% increase. The company also saw a substantial improvement in profitability, with a 34.41% increase in profit. The company's net worth moved up by a moderate rise of 2.15%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
51.47%
Revenue from Operations
62.69%
Total Assets
34.82%
Profit or Loss
34.41%
Net Worth
2.15%
EBITDA
685.75%

What is the Ownership and Shareholding Structure of Kras Pharmaceuticals?

In 2021, Kras Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹3.22 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 2.99 Cr
  • Indian Bank : 0.24 Cr

Latest Charge Details

DateLenderAmountStatus
30 Dec 2023Hdfc Bank Limited₹5.87 MOpen
09 Sep 2022Hdfc Bank Limited₹2.40 CrOpen
29 Dec 2021Indian Bank₹2.38 MOpen

How Many Employees Work at Kras Pharmaceuticals?

Unlock and access historical data on people associated with Kras Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kras Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kras Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Kras Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Kras Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Charges

    A charge with Hdfc Bank Limited of Rs. 2.40 Cr registered on 09 Sep 2022 with Charge ID 100676472 was modified on 08 Aug 2024.

    08 Aug 2024

  • Balance Sheet

    Kras Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna.

    31 Mar 2024

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.59 Cr with Charge ID 100922316 was registered on 30 Dec 2023.

    30 Dec 2023

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.40 Cr with Charge ID 100676472 was registered on 09 Sep 2022.

    09 Sep 2022

  • Charges

    A charge with Indian Bank amounted to Rs. 0.24 Cr with Charge ID 100560160 was registered on 29 Dec 2021.

    29 Dec 2021

Frequently asked questions

  • Kras Pharmaceuticals Private Limited was incorporated on 27 Sep 1985.

  • The authorized share capital of Kras Pharmaceuticals Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.50 Cr.

  • Currently 4 directors are associated with Kras Pharmaceuticals Private Limited.

    • Rupesh Kumar
    • Rupesh Kumar
    • Ravi Shankar
    • Vinita Bhushan
  • As per Ministry of Corporate Affairs (Mca), the registered address of Kras Pharmaceuticals Private Limited is C/O Kras Pharmaceuticals Private Ltd C-15 2Nd Phase, Industrial Area India, Fatuha, Bihar, 803201.

  • The corporate identification number (CIN) of Kras Pharmaceuticals Private Limited is U00304BR1985PTC002219 and the company number is 002219 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2022, the revenue trend for Kras Pharmaceuticals Private Limited has risen by 51.47%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Kras Pharmaceuticals Private Limited has experienced an upsurge of 2.15%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Kras Pharmaceuticals Private Limited amount to ₹ 3.22 Cr.

  • The most recent Balance Sheet for Kras Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Drug Formulation & Development